Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?

Le Cam Y. et al, (2018), Clinical Pharmacology and Therapeutics

Maximising value from a United Kingdom Biomedical Research Centre: study protocol

Greenhalgh T. et al, (2017), Health research policy and systems, 15

An assessment of implications of adaptive licensing for pharmaceutical intellectual property and regulatory exclusivity rights in the European Union

(2016), Clinical Pharmacology and Therapeutics, 100, 743 - 753

Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways

Pani L. and Barker R., (2016), Clinical Pharmacology and Therapeutics, 100, 730 - 742